$CDNA Cashflow Statement | Understand Stock

$CDNA

$70.53 +$1.43 (2.07%) Close

$CDNA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Net loss
Net (loss) income
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Stock-based compensation
Asset impairments and write-downs
Impairment of intangible asset and associated construction in progress
Depreciation and amortization
Amortization of right-of-use assets
Unrealized loss on long-term marketable equity securities
Realized gain on sale of long-term marketable equity securities, net
Loss on disposal of asset
Gain on settlement of obligation and recovery of written-off investment
Revaluation of common stock warrant liability to estimated fair value
Revaluation of contingent consideration to estimated fair value
Other non-cash items
Amortization of premium and accretion of discount on marketable securities, net
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid and other assets
Accounts payable
Accrued compensation
Accrued and other liabilities
Accrued royalties
Operating lease liabilities, net
Refund liability - CMS advance payment
Deferred taxes
Net cash provided by (used in) operating activities

Investing activities:
Maturities of marketable securities
Purchases of short-term marketable securities
Purchases of marketable securities
Purchase of corporate equity securities
Sale of corporate equity securities
Additions of capital expenditures
Noncash or Part Noncash Acquisition, Intangible Assets Acquired
Acquisition of intangible assets
Acquisition of business, net of cash acquired
Investment in equity securities
Net cash provided by (used in) investing activities

Financing activities:
Proceeds from issuance of common shares
Public Offering
At The Market Equity Offering
Total proceeds from issuance of common shares

Payment of contingent consideration
Principal payments on finance lease obligations
Repurchase and retirement of common stock
Proceeds from exercise of warrants
Proceeds from exercise of stock options
Proceeds from issuance of common stock under employee stock purchase plan
Taxes paid related to net share settlement of restricted stock units
Net cash used in financing activities
Effect of exchange rate changes on cash and cash equivalents
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents, and restricted cash at beginning of period
Cash, cash equivalents, and restricted cash at end of period
Supplemental disclosures of cash information
Cash paid for interest
Cash paid for income taxes
Supplemental disclosures of non-cash operating, investing and financing information
Shares issued in lieu of payment
Operating lease right-of-use assets
Purchases of capital expenditures in accounts payable and accrued liabilities
Employee stock purchase plan shares included in accrued compensation
Contingent consideration

Comments